Chicago Capital Management, LLC
Q3 2025 13F-HR Holdings
Net value change ($000)
-24,296
(-17.9%)
New positions
5
Sold out positions
13
Turnover %
235.4%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| VRNA | 13,830 | NEW |
| TRML | 5,376 | NEW |
| PBBK | 2,796 | NEW |
| CCRD | 1,751 | NEW |
| BankFinancial CORP | 346 | NEW |
| HPE | 297 | 15.3% |
| CFSB | 110 | 23.0% |
Top Reduces (Value $000, Stocks/ETFs)
| SpringWorks Therapeutics, Inc. | -9,409 | -100.0% |
| BPMC | -7,691 | -100.0% |
| OPOF | -7,273 | -100.0% |
| Vigil Neuroscience, Inc. | -3,838 | -100.0% |
| PENNS WOODS BANCORP INC | -2,355 | -100.0% |
| TRIUMPH GROUP INC | -2,189 | -100.0% |
| Southern States Bancshares, Inc. | -1,689 | -100.0% |
| CLG | -1,631 | -100.0% |
| Verve Therapeutics, Inc. | -1,408 | -100.0% |
| AHC | -693 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|